Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist
Keywords: EP4 receptor antagonist; Structure-activity relationship (SAR); Prostaglandin E2; Inflammation; Pain; Autoimmune diseases; Cancer; Clinical candidate;